10 insiders reported 32 Form 4 transactions for CapsoVision, Inc (CV) over the past 18 months (most recent 2026-07-21). Recent activity: HARARI ELIYAHOU ET AL (10% Owner) Buy 61,068 shares, HARARI ELIYAHOU ET AL (10% Owner) Buy 81,300 shares, HARARI ELIYAHOU ET AL (10% Owner) Buy 13,850 shares, GOUW JULIA S (Director) Buy 2,022 shares, Tsai Chen Lung (Director) Buy 2,022 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-21 | HARARI ELIYAHOU ET AL | 10% Owner | Buy | 61,068 | $410,988 |
| 2026-07-10 | HARARI ELIYAHOU ET AL | 10% Owner | Buy | 81,300 | $495,117 |
| 2026-07-07 | HARARI ELIYAHOU ET AL | 10% Owner | Buy | 13,850 | $101,811 |
| 2026-07-01 | GOUW JULIA S | Director | Buy | 2,022 | $15,327 |
| 2026-07-01 | Tsai Chen Lung | Director | Buy | 2,022 | $15,327 |
| 2026-07-01 | Harari Michele | Director | Buy | 2,022 | $15,327 |
| 2026-07-01 | King Wen-Herng Henry | Director | Buy | 2,022 | $15,327 |
| 2026-07-01 | Kuo Hui Ying | Director | Buy | 2,022 | $15,327 |
| 2026-07-01 | Imperial Joanne Carol | Director | Sell | 1,200 | $8,587 |
| 2026-07-01 | Imperial Joanne Carol | Director | Buy | 2,022 | $15,327 |
| 2026-05-06 | Atkinson Douglas Patrick | Head of Global Sales | Buy | 6,505 | $3,682 |
| 2026-05-06 | Atkinson Douglas Patrick | Head of Global Sales | Buy | 30,030 | $11,000 |
| 2026-05-06 | Atkinson Douglas Patrick | Head of Global Sales | Buy | 36,036 | $10,317 |
| 2026-05-06 | Atkinson Douglas Patrick | Head of Global Sales | Buy | 34,786 | $19,692 |
| 2026-02-06 | Tsai Chen Lung | Director | Buy | 20 | $83 |
| 2025-12-31 | Tsai Chen Lung | Director | Buy | 2,887 | $30,862 |
| 2025-12-31 | Harari Michele | Director | Buy | 2,887 | $30,862 |
| 2025-12-31 | King Wen-Herng Henry | Director | Buy | 2,887 | $30,862 |
| 2025-12-31 | GOUW JULIA S | Director | Buy | 2,887 | $30,862 |
| 2025-12-31 | Imperial Joanne Carol | Director | Buy | 2,887 | $30,862 |
| 2025-12-31 | Kuo Hui Ying | Director | Buy | 2,887 | $30,862 |
| 2025-08-22 | Petersen Rebecca Ann | Director of Clinical Affairs | Buy | 24,834 | $9,189 |
| 2025-07-08 | HARARI ELIYAHOU ET AL | Insider | Buy | 3.2M | $0 |
| 2025-07-08 | HARARI ELIYAHOU ET AL | Insider | Buy | 517,759 | $0 |
| 2025-07-08 | HARARI ELIYAHOU ET AL | Insider | Buy | 517,759 | $0 |
Source: SEC Form 4 filings · as of 2026-07-21